CORAL GABLES, Fla., Nov. 15, 2011 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced its financial results for the third quarter and nine months ended September 30, 2011. For the three months ended September 30, 2011, the Company reported a net loss of $1,127,841, or $0.05 per basic and diluted share, compared to a net loss of $903,985, or $0.05 per basic and diluted share, for the same period in 2010. For the nine months ended September 30, 2011, the Company reported a net loss of $4,039,128, or $0.19 per basic and diluted share, compared to a net loss of $3,277,569, or $0.18 per basic and diluted share, for the same period in 2010.
